The Fund was right to suspend grants to Uganda.

Impressive achievements and difficulties, the editorial concludes (Lancet.. The Fund was right to suspend grants to Uganda, says Lancet editorialhas with the suspension of its grants to Uganda, Global Fund to Fight AIDS, Tuberculosis and Malaria, a principled stand against misuse of funds , although the country for their achievements honored in the fight against HIV / Aids a Lancet editorial says (Lancet, the Global Fund last week announced the suspension of five grants worth more than $ 200 million after an audit of one of the grants by PricewaterhouseCoopers found evidence of serious mismanagement by the Ugandan Ministry of Health, Project Management Unit, which established to grants was to implement.

On 20 July 2007, before the market opened, Biovail issued a press release that they receive an non – approval letter from the FDA for its New Drug Application for BVF-033. On this news, shares of Biovail was $ 25.51 per share to 20.12 – and Forest In order linaclotide Stage 3 Chronic Constipation data availableIronwood Pharmaceuticals, Inc. and Forest Laboratories today announced that they showcase Phase 3 chronic constipation in patients clinical studies on Linaclotide was, an investigational guanylate cyclase guy – C agonists for the treatment for irritable bowel syndrome with constipation and chronic constipation , during the 2010 Digestive Disease Week Annual Meeting of held in New Orleans from 1 May to 5th May 2010.

Other Posts From "obstetrics":

Related Posts